Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients
- 8 February 2025
- journal article
- hepatobiliary pancreas
- Published by Springer Nature in European Radiology
- Vol. 35 (3) , 1451-1463
Abstract
Objectives Tumor collagen is vital in chemotherapy resistance of pancreatic cancer (PC), but its non-invasive evaluation remains challenging. This study aims to investigate the association of variables derived from dual-energy CT with the collagen ratio (CR) of PC and to determine the prognostic value of CR in unresectable diseases. Materials and methods A total of 83 patients with resected PC and 71 patients with unresectable PC were enrolled. In the resected group, the correlation between the tumor CR and variables of dual-energy CT was analyzed. In the unresectable group, Cox regression analyses were conducted to investigate the prognostic value of dual-energy CT-predicted CR and other clinicoradiological indicators. Results The patients with resected PC were divided into low and high-CR sets with a threshold of 55%. In the resected group, the extracellular volume fraction calculated by the iodine concentration (ECV_IC) was the only predictor of tumor CR according to univariate and multivariate analysis (hazard ratio [HR] (95% confidence interval [CI]):1.19 [1.03–1.37]). The correlation coefficient r was 0.26 (p = 0.02) between ECV_IC and specific CR values. In the training set of unresectable PC group, ECV_IC (HR (95% CI): 0.94 (0.89–0.99), p = 0.03) and contrast-enhanced pattern (CEP) (HR (95% CI): 3.20 (1.41–7.27), p = 0.01) were independent prognostic factors for overall survival. The nomogram model was constructed and showed a good performance. Conclusion The ECV_IC is a non-invasive indicator of tumor CR in PC. The ECV_IC and CEP have the potential to predict the prognosis of unresectable PC. Key Points Question Non-invasive evaluation of tumor collagen, a vital determinant of chemotherapy resistance of pancreatic cancer, remains challenging. Findings Tumor collagen ratio can be noninvasively predicted by extracellular volume fraction based on iodine concentration. Clinical relevance The nomogram model composed of extracellular volume fraction and contrast-enhanced pattern can serve as an effective and convenient tool for stratifying the prognosis of patients with unresectable pancreatic cancer. Graphical AbstractKeywords
Funding Information
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission (22490760800)
- Shanghai Minhang Health And Family Planning Commission (2020MWFC05)
- Shanghai Xuhui District Science and Technology Committee (23XHYD-13)
- Shanghai Anticancer Association SOAR Project (SACA-AX202309)
- Shanghai Anticancer Association EYAS Project (SACA-CY23B05)
This publication has 27 references indexed in Scilit:
- Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9European Radiology, 2023
- CT for the evaluation of myocardial extracellular volume with MRI as reference: a systematic review and meta-analysisEuropean Radiology, 2023
- Extracellular volume fraction obtained by dual-energy CT depicting the etiological differences of liver fibrosisAbdominal Radiology, 2023
- Nomogram based on CT–derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinomaEuropean Radiology, 2022
- Tumor fibrosis correlates with the survival of patients with pancreatic adenocarcinoma and is predictable using clinicoradiological featuresEuropean Radiology, 2022
- Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoterBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapyAbdominal Radiology, 2020
- Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resectionEuropean Radiology, 2020
- Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experienceMolecular Oncology, 2020
- Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinomaEuropean Radiology, 2019